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ABSTRACT 
A high-performance liquid chromatographic method using ultraviolet detection to quantitate human plasma concentrations of 
cortisone simultaneously with cortisol and corticosterone is described. The method is based on the use of an octadecyl silica column 
(100 mm x 2 mm I.D., 3 pm). an ultraviolet absorbance detector (242 nm) with a 10 mm path length flow-cell, and a mobile phase 
composed of waterrtetrahydrofuran-acetonitrile (82: 10:8, v/v) containing 5 ml/l triethylamine and citric acid to adjust the pH of the 
buffer to 6.5. Flumethasone is used as the internal standard. The detection limit of the method for the three steroids is 300 rig/l using a 
l-ml sample. The average inter-assay coefficient of variation for cortisone is 3.3% and the average recovery is 100.8%. Possible 
interferences from common drugs and endogenous and exogenous steroids in the method have been studied. Plasma concentrations 
(drawn from 8 to 10 a.m.) of cortisone and corticosterone for 43 normal volunteers have been determined. 
INTRODUCTION 
Cortisone (E) is a physiologically inactive steroid 
formed by the oxidation of cortisol (F) by the 
enzyme 11 P-hydroxysteroid-dehydrogenase (11 p- 
OHSDH) present in various tissues. It is reduced 
back into active cortisol, and an equilibrium 
E-F exists in many human tissues such as liver, 
kidney, adipose, brain, lung, testis, uterus, placen- 
ta, and parotid gland [l-3]. Human pharmaco- 
kinetics [4] and metabolism of F and E, their 
interconversions and equilibria in different patho- 
logic conditions [5-71, and the dual nature (oxo- 
reductase and dehydrogenase) of 1 l/?-OHSDH 
[3,8] have all been studied quite extensively. 
F and E are usually quantitated by independent 
methods only. In the early days E was analyzed 
* Corresponding author. 
after initial extraction from plasma and purifica- 
tion by Sephadex LH-20 column chromatogra- 
phy, followed by competitive protein binding 
assay [9]. In 1973 Srivastava et al. [lo] introduced 
a radioimmunoassay (RIA) for E. This method is 
the only available choice for human plasma and 
saliva and it requires initial extraction and puriti- 
cation by thin-layer or high-performance liquid 
chromatography (HPLC) [l 11. Human urine con- 
tains fairly high concentrations of free E (54 + 
50 ,ug per 24 h) and F (22 f 18 ,ug per 24 h) and 
both steroids have been simultaneously, accurate- 
ly, and precisely measured by HPLC-UV [ 121. 
Total human plasma and urine E concentrations 
can also be estimated by gas chromatography 
after enzymatic hydrolysis, extraction, purifica- 
tion, and derivatization [ 131. Although HPLC is a 
readily available, powerful, and simple tool re- 
quiring no prior derivatization, very little is 
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known about its use for determining the low levels 
(< 30 pg/l) of free human plasma E concentra- 
tions. However, Wade and Haegele [ 141 published 
a HPLC-UV method for human saliva E and F 
assays. It has many weak features: the HPLC 
system is unnecessarily sophisticated, the analyti- 
cal column is too long (250 mm x 2 mm I.D.), the 
nature of mobile phase mandates column thermo- 
stating at 5O”C, and the extraction is cumber- 
some, involves deproteinization of saliva. and 
requires up to 6 ml of sample. 
We recently developed a simple, sensitive (de- 
tection limit of 300 rig/l using 1 ml of plasma), and 
highly reproducible HPLC-UV method that dis- 
tinctly separated E, F, I 1-deoxycortisol (S), cor- 
ticosterone (B), deoxycorticosterone (DOC), 
dexamethasone (D), 17-hydroxyprogesterone (17- 
OHP), and progesterone (P) [ 151. In this paper we 
describe a sensitive, specific analysis of human 
plasma E by reversed-phase HPLC and provide 
comprehensive precision, accuracy, recovery, and 
linearity data for the method. We have also 
determined plasma concentrations (drawn from 8 
to 10 a.m.) of B and E in 43 normal volunteers. 
EXPERIMENTAL 
Rrugmts and muteriuls 
Cortisol (98.9%) was obtained from the Na- 
tional Institute of Standards and Technology 
(Gaithersburg, MD, USA), and cortisone (98%) 
from Sigma (St. Louis, MO, USA). Flumethasone 
and corticosterone were from Steraloids (Wilton, 
NH, USA). HPLC-grade acetonitrile (ACN), 
methanol, and tetrahydrofuran (THF), were from 
Burdick & Jackson (Muskegon, MI, USA). Re- 
agent-grade triethylamine and citric acid were 
from Fisher Scientific (Fair Lawn, NJ, USA). 
Steroid-stripped plasma was from Biocell (Car- 
son, CA, USA). The all-PTFE C18 solid-phase 
extraction (SPE) columns (Tef Elutor), 2 ml 
capacity and containing 200 mg of material, were 
obtained from Versa Prep Lab Systems (Nanuet, 
NY, USA). SPE was carried out with Baker SPE 
systems (J. T. Baker, Phillipsburg, NJ, USA). The 
lo-ml all-PTFE tubes (Oak Ridge type from 
Nalgene) used throughout the extraction work 
were from VWR Scientific (Chicago, IL. USA). 
(Note: PTFE tubes are not essential for the 
extraction work.) 
Instrument and mobile please 
The HPLC unit consisted of a Model L-6000 
pump (Hitachi, Tokyo, Japan), a Model 710B 
WISP autosampler (Waters, Milford, MA, USA), 
an octadecyl silica (ODS) 3-pm Shandon Hypersil 
column (100 mm x 2 mm I.D.) (Keystone Scien- 
tific, Bellefonte, PA, USA), a Model 480 ultra- 
violet detector (Waters) with a 10 mm path length 
flow-cell set at 242 nm, and a Model D-2000 
integrator-plotter (Hitachi). The mobile phase 
was a mixture of water-THF-ACN (82: 10:8, v/v), 
containing 5 ml/l triethylamine and citric acid to 
adjust the pH to 6.5. The flow-rate was 0.6 ml:’ 
min. 
Standurd solutions 
A 250-ml aliquot of a primary stock solution 
was prepared by dissolving 25 mg of cortisone in 
methanol. Working standard solutions were pre- 
pared in either steroid-stripped serum or meth- 
anolic saline (20 ml of methanol and 8 g of sodium 
chloride per liter) and contained 1, 4. 10, 20, 40, 
80, and 200 pg/l cortisone. The aqueous and 
serum-based standards were used in no set order. 
In all cases. serial standardizations were per- 
formed. The working internal standard solution 
contained 20 ng of flumethasone per 50 ~1 of 
solution. 
Extruction 
The extraction procedure for all the samples 
using Tef Elutor SPE Cl8 columns is described 
elsewhere [ 151. The final nitrogen gas-evaporated 
residue was reconstituted in 50 ~1 of mobile phase, 
and 25 ~1 of the solution were injected into the 
HPLC system using an autosampler. 
RESULTS AND DISCUSSION 
Calibration 
A series of standards covering the range O- 
200 pg/l were used in daily work. The regression 
line between the ratio of peak heights (component 
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peak height/internal standard peak height) and 
the concentration of cortisol was calculated and 
used for determining the unknowns. A typical 
regression line was y = 0.0009 + 0.2840~ (r2 = 
0.9997). 
Linearity 
Steroid-stripped plasma samples were spiked 
with cortisone in the concentration range O- 
200 ,ug/l and analyzed several times (n > 20) and 
the absorbances of the standards were linear 
throughout the range. 
Precision 
Inter-assay and intra-assay coefticients of vari- 
ation (C.V.) were determined using three plasma 
pools on the range 4.5-30 pg/l (covering the 
normal human range). The data are presented in 
Table I. The average inter-assay C.V. for E was 
3.3%. 
Accuracy 
E was added to steroid-stripped plasma in the 
concentration range (2-200 pg/l) we encountered 
in our work. We determined both inter-assay and 
intra-assay recoveries for these samples by the 
method (Table 11). The average inter-assay recov- 
ery was 100.8%. 
Limit of’ detection 
The detection limit of the assay was 300 rig/l 
TABLE I 
PRECISION DATA FOR HUMAN PLASMA CORTISONE 
ASSAY (n = 8) 
Concentration C.V. 
(mean f S.D.) @g/ml) (%) 
Inler-ussu_~ 
4.88kO.19 3.9 
15.99 * 0.50 3.1 
29.87 k 0.87 2.9 
I?lWU-USSUJ, 
4.76+0.12 2.5 
15.64 + 0.45 2.9 
29.15*0.61 2.1 
TABLE II 
RECOVERY DATA FOR CORTISONE IN STEROID- 
STRIPPED PLASMA 
Spiked Measured Recovery 
@g/l) (mean & S.D.) (/igil) (%) 
Inter-ussuJ in = 8) 
2.0 2.1 *0.1 105.0 
8.0 8. I + 0.2 101.3 
20.0 19.8 * 1.2 99.0 
40.0 40.2 k 1.5 100.5 
80.0 79.6 * 2.8 99.5 
200.0 198.7 * 5.3 99.4 
ktra-uxy (n = 6) 
2.0 2.1 kO.1 105.0 
20.0 20.1 & 1.0 100.5 
80.0 80.2 k 2.2 100.3 
200.0 199.2 k 4.7 99.6 
using 1 ml of sample, at a signal to noise ratio of 
3: 1. This detection limit is lower than the normal 
values observed in human populations. 
Selectivity 
The assay was reasonably more specific than 
the RIA method [lo]. We determined the reten- 
tion times of many endogenous and exogenous 
steroids and commonly used drugs [15]. 
Earlier HPLC methods for quantitating gluco- 
corticoids in human plasma [ 16-221 had the 
following drawbacks. (1) Most of the analytical 
columns were long (2 250 cm) and contained 5- or 
IO-pm packing materials which were responsible 
for poor resolutions and increased assay times 
[16-221. (2) Analytical columns were thermo- 
stated for improving the resolution and decreas- 
ing the assay time per sample [16,17,19,20]. (3) 
Earlier mobile phase compositions were not con- 
ducive for good resolution and short assay time 
[ 16-221. (Note: progesterone is generally coex- 
tracted with the glucocorticoids and elutes very 
late in the reversed-phase method.) (4) It is not 
clear if the earlier workers [ 16-221 took advantage 
of the possible higher sensitivities in the assay by 
using a minibore column and longer path length 
19X 
flow-cell as shown by Taylor rt al. [23]. One of the 
most successful mobile phase compositions for 
the separation of glucocorticoids contains THF 
[20], a solvent of intermediate eluotropic behavior 
between methanol (low) and ACN (high). Greater 
flexibility of mobile phase optimization results 
when a binary mixture of THF and ACN is 
chosen. Dawson et al. [20] using a mobile phase of 
THF-ACN-water (12:10.5:77.5, v/v) and a C8 
column (5 pm, 250 mm x 4.5 mm I.D.) at 50°C 
resolved E, F, B, D, etc. very nicely. However, 
their detection limit was 2 15 pg/l. We modified 
the method of Dawson et ul. [20] using a minibore 
ODS column (100 mm x 2 mm I.D., 3 pm, 
theoretical plate count of U. 8000) and a detector 
with a IO-mm path length flow-cell. We also 
improved upon earlier SPE methods by ensuring 
> 90% extraction efficiencies [ 151, and optimized 
the composition of the mobile phase of THF- 
ACN-citrate buffer (10:8:82, v/v) for a good 
isocratic resolution at ambient temperature of 
many endogenous and exogenous steroids. The 
cumulative effects of our modifications of the 
method resulted in a detection limit of 300 rig/l for 
the glucocorticoids E, F, and B [15]. Slight 
modifications of the mobile phase would enable 
the separation of any combination of synthetic 
and endogenous steroids. We investigated the 
possibility of using still shorter columns (75 or 
50 mm x 2mm I.D.) in the hope of reducing the 
analysis ‘time per sample, but found that the 
optimal mobile phase composition that would 
A 
w 
Fig. I. Representative liquid chromatograms of(A) reagent water blank, (B) 25 ng each of E. F. B. S. ilumethasone (FLU) and 50 ng each 
of DOC and 17-OHP and (C) I-ml plasma extract containing 12.2. /ig;‘l E. 23.76 j&l F. 1. I ~~,e/l B. and 20 /lg:I FLU (internal standarci). 
Refer text for other abbreviations, Integrator attenuation is 2”. 
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resolve the different glucocorticoids will preclude 
it. However, the assay time per sample can be 
reduced to less than 20 min if progesterone 
(especially in female patient samples) is removed 
by including a wash step of methylene chloride 
and hexane (5:95, v/v) either at the beginning of 
the extraction or just prior to elution at the end 
with methanol in the SPE [15]. 
Fig. 1 shows representative chromatograms 
obtained in this work. The peaks are sharp and 
baseline-resolved. The assay time per sample is ca. 
20 min. The present work, in conjunction with our 
earlier paper [ 151 for the simultaneous analysis of 
F and B, would form a good and comprehensive 
HPLC-UV method for the three most relatively 
abundant glucocorticoids (E, F, and B) in human 
plasma. 
Cortisone is a pharmacologically inactive 
steroid (the 11 -OH group is essential for activity) 
but the equilibrium E++F lies predominantly 
towards the right (reduction) in the liver. Liver is 
the largest site for the reduction of cortisone, and 
the magnitude of this reduction is greater than the 
magnitude of oxidation in kidney or testis [3]. In 
cirrhosis the equilibrium in the liver is maintained 
but the half-life of F is increased from ca. 1 .O h to 
5 h [24]. The kidney, parotid gland, placenta, and 
testis are major sites where F is oxidized predomi- 
nantly to E [ 1,251. Among the oxidative tissues 
kidney ranks highest and testis second [25]. It has 
been shown that the renal 1 I/?-OHSDH protects 
the kidney from the mineral corticoid actions of F 
[25,26]. In kidney failure, the plasma level of E is 
much lower than in normal controls [27]. Hyper- 
thyroid individuals convert F more readily to E [6] 
and the opposite is true in hypothyroidism and 
inflammatory diseases [5,6]. In pregnancy and 
during oral contraceptive use the total concentra- 
tions of F and E are higher than normal but the 
concentrations of the free compounds change 
little. Thus, the disposition of E+-+F equilibrium is 
different in different tissues and it can vary 
depending upon its pathological status [5,6,24,27] 
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Fig. 2. Histogram of human plasma cortisone of 43 normal volunteers (drawn between 8 and 10 a.m.). 
to Monder [25] the selectivity, specificity, and 
extent of glucocorticoid responses in tissues is 
modulated by the reversible function of the 
enzyme 1 lb-OHSDH and the time variable needs 
of the tissue. 
In the light of all the facts on the E-F 
equilibrium and the enzyme llfl-OHSDH, it 
seems that a better way to monitor the gluco- 
corticoid activity would be to determine simul- 
taneously, by this HPLC-UV method, the con- 
centrations of the three relatively abundant com- 
pounds E, F, and B rather than the most abun- 
dant F alone by RIA. From our limited study we 
find that the plasma concentration of E is about 
25% of the concentration of F while that of B is 
about 5-10%. Thus a possible additional 30-35% 
glucocorticoid activity would be of much signif- 
icance. Lewbart and Elverson [ 121 suggested that 
the urinary free E concentration cannot be ignor- 
ed because of its variable interconversion with 
cortisol in viva. 
Normal values 
Cortisone. The values for 43 normal volunteers 
(aged 20-70 years; drawn between 8 and 10 a.m.; 
non-fasting) are plotted as a histogram (Fig. 2). 
The histogram shows a Gaussian distribution. 
The concentration (mean f SD.) of the sample is 
19.36 + 6.6 pg/l (drawn between 8 and 10 a.m.). 
This value compares quite favorably with those 
reported by Sippell et al. [29] and determined by 
RIA following Sephadex column chromatogra- 
phy(17.3k3.1 pg/lfor 12males; 13.5_t2.9for 12 
females; samples drawn between 9 and 10 a.m.). 
Corticosterone. The values for the 43 samples 
determined by this HPLC method do not fall into 
a Gaussian distribution pattern (Fig. 3). We cal- 
culated the concentrations (mean + S.D.) using 
statistical methods to be 1.78 k 0.60 pg/l. The 
values are lower than those in earlier reports [29] 
perhaps due to the higher proportion of males (cu. 
85%) the wider range of the age of our volun- 
teers. the slightly different blood drawing times 
0 to 1 1 to2 2 to 3 3 to 4 4 to 5 5 to 6 6 to 7 7 to 8 8 to 9 9 to 10 
Corticosterone (*g/l) 
1 
Fig. 3. Histogram of human plasma corticosterone of 43 normal volunteers (drawn between X and IO a.m.) 
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(8-10 a.m.) and the larger population size of our 
samples compared to earlier methods. 
CONCLUSION 
The outlined reversed-phase ambient-tempera- 
ture HPLC method is simple, sensitive, specific, 
accurate, and precise and a viable alternative to 
the present and only RIA method for human 
plasma E measurement. The method is economi- 
cal since it cuts down the amount of the mobile 
phase used (flow-rate of 0.6 ml/min) and the assay 
time per sample (compared to earlier methods 
[ 16-221). The big advantage of this HPLC method 
is that one can simultaneously measure many 
endogenous and exogenous steroids. An endo- 
genous steroid profile consisting of E, F, B, S, 
DOC, 17-OHP, and P is quite useful in a detailed 
study of different types of adrenal hyperplasia as 
shown by Ji-qing et al. [30]. Also a knowledge of 
the plasma concentrations of the glucocorticoids 
(E, F, and B) instead of just the F level could be 
more informative in investigating the pathologi- 
cal conditions of different organs (liver, kidney, 
adrenal, and thyroid gland), inflammatory dis- 
eases and hypothalmiccpituitary-adrenal axis 
dysfunctions. 
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